(Total Views: 563)
Posted On: 11/13/2025 8:00:04 PM
Post# of 158772
Re: sherlock57 #158431
Quote:
What I get from these two trials is... the drugs don't work very well if you have liver mets.
Recall our mcrc patient with a solitary hepatic metastasis underwent liver resection following a reduction (43%) after FOLFOX + leronlimab, and remains alive with no evidence of disease (NED) at ∼57 months.
(13)
(0)
